Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 4, 2022

View Archived Issues

The enzyme NOX4 is essential for the antidiabetes effect of exercise

YAP1 promotes salivary gland regeneration after injury

Novel inhibitors of fungal FA biosynthesis show broad-spectrum antifungal activity

Medshine Discovery discloses EZH2 inhibitors

Leo Pharma patents IL-17 modulators

Chinese researchers synthesize new SOS1 inhibitors

Roche identifies new ENPP2 inhibitors

Arbutus Biopharma presents new HBV and/or HDV capsid assembly inhibitors

Discovery of triple-action inhibitor for the treatment of neurodegenerative diseases

uPA-uPAR blockade protects intestinal epithelial barrier from inflammation-induced damage

Novel allosteric inhibitor of tumor-promoting PPI between AIMP2-DX2 and HSP70

Ovid licenses KCC2 transporter activators from AstraZeneca

Jemincare's JMB-2002 retains efficacy against Omicron variant of SARS-CoV-2

German grant supports Evotec's development of EVT-075 for COVID-19

Amberstone Biosciences completes financing round to support immuno-oncology pipeline

PLCbeta4 blockade is a potential approach for treating uveal melanoma

Ascletis announces new oral direct-acting antivirals being developed for SARS-CoV-2 infection

Kyverna licenses CAR T construct for use in autologous and allogeneic therapies

Garvan Institute awarded grant to investigate new treatment approach for pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...